← SynDRA
CELIPROLOL
SynDRA canonical compound SYN0001592 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | ADRB2 |
| Mechanism of action | Adrenergic receptor antagonist |
| Indication | Ehlers-Danlos syndrome (EDS) |
| Disease area | genetics |
All known targets
- ADRB1
- ADRB2
- ADRA2A
- ADRA2B
- ADRA2C
- Htr1a
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRB2 PARTIAL AGONIST
- Beta-2 adrenergic receptor partial agonist
- ADRA2A ANTAGONIST
- Adrenergic receptor alpha-2 antagonist
- ADRA2C ANTAGONIST
- ADRA2B ANTAGONIST
- ADRB1 ANTAGONIST
- Beta-1 adrenergic receptor antagonist
Drug classes
- Adrenergic Agents
- Adrenergic Antagonists
- Adrenergic beta-1 Receptor Antagonists
- Adrenergic beta-Antagonists
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympathomimetics
- Vasodilator Agents
ATC classes
- C07A · BETA BLOCKING AGENTS
Cross-references
Synonyms
- DL-Celiprolol
- selectol
- celiprolol hydrochloride
- celiprolol HCl
- celiprolol monohydrochloride
- Celiprolol pch
- ACER-002 FREE BASE
- ACER002 FREE BASE
- Celiprolol hcl
- Selectol (TN)
- Celiprololum
- Celiprolol PCH
- UL/1677
- RHC-5320A
- DRB57K47QC
- ST1396
- RefChem:124293
- DTXCID90259
- REV5320A
- REV 5320A
- C07AB08
- Celiprolol (INN)
- CELIPROLOL [INN]
- ST-1396
- Celiprolol [INN:BAN]
- Celiprololum [INN-Latin]
- CCRIS 3400
- RHC 5320 A
- EINECS 260-497-7
- UNII-DRB57K47QC
- BRN 2776298
- Edsivo
- CELIPROLOL [MI]
- CELIPROLOL [VANDF]
- CELIPROLOL [WHO-DD]
- SCHEMBL49415
- GTPL9064
- SCHEMBL29408752
Look up CELIPROLOL in the interactive SynDRA portal →